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General considerations:  
Unless indicated otherwise, reactions performed under inert atmosphere were 
carried out in oven-dried glassware in a glovebox under a nitrogen atmosphere purified 
by circulation through RCI-DRI 13X-0408 Molecular Sieves 13X, 4x8 Mesh Beads and 
BASF PuriStar® Catalyst R3-11G, 5x3 mm (Research Catalysts, Inc.). Anhydrous 
dichloromethane was purified by sparging with nitrogen for 15 minutes and then passing 
under nitrogen pressure through a column of activated A2 alumina (Zapp’s). CD2Cl2 was 
purchased from Cambridge Isotope Laboratories, dried over calcium hydride, then 
degassed by three freeze-pump-thaw cycles and vacuum-transferred prior to use. 1H and 
19F NMR spectra were recorded on Varian Mercury 300 MHz spectrometers at ambient 
temperature, unless denoted otherwise. 1H NMR chemical shifts are reported with respect 
to internal solvent: 5.32 ppm for CD2Cl2. 19F NMR chemical shifts are reported with 
respect to an external standard of C6F6 (-164.9 ppm). Elemental analysis was conducted 
by Robertson Microlit Labs (Ledgewood, NJ). 
Electrochemical measurements were recorded with a Pine Instrument Company 
AFCBP1 bipotentiostat using the AfterMath software package. Cyclic voltammograms 
were recorded on ca. 2 mM solutions of the relevant complex in the glovebox at 20 °C 
with an auxiliary Pt-coil electrode, a Ag/Ag+ reference electrode (0.01 M AgNO3, 0.1 M 
[nBu4N+][PF6-] in MeCN), and a 3.0 mm glassy carbon electrode disc (BASI). The 
electrolyte solution was 0.1 M [nBu4N+][PF6-] in CH2Cl2. All reported values are 
referenced to an internal ferrocene/ferrocenium couple. 
Unless otherwise noted all chemical reagents were purchased from commercial 
sources and used without further purification. Ferrocene, decamethylferrocene, 2,6-di-
tert-butyl-4-methylpyridine (DTBMP), [2.2.2]-diazabicyclooctane (DABCO) and 
tris(pentafluorophenyl)borane were purchased from SigmaAldrich and sublimed prior to 
use; B(C6F5)3 was sublimed twice prior to use. DABCO-2H2O2 and H(OEt2)2BArF24 
were prepared according to the literature methods.1,2 
 
NMR Scale Reactions of Cp2Fe, Cp*2Fe, B(C6F5)3, and O2 
B(C6F5)3 and O2: A solution of B(C6F5)3 (0.0203 g, 0.039 mmol) in CD2Cl2 (0.6 mL) was 
degassed via three freeze-pump-thaw cycles in a J. Young NMR tube. An atmosphere of 
O2 was admitted to the headspace of the tube and the reaction was continuously inverted 
over 24 hours at room temperature, monitoring by 19F NMR spectroscopy (see Figure 
S1). 
 
Cp*2Fe and O2: A solution of Cp*2Fe  (0.0138 g, 0.042 mmol) in CD2Cl2 (0.6 mL) was 
degassed via three freeze-pump-thaw cycles in a J. Young NMR tube. An atmosphere of 
O2 was admitted to the headspace of the tube and the reaction was continuously inverted 
over 24 hours at room temperature, monitoring by 1H NMR spectroscopy (see Figure 
S2). 
 
Cp*2Fe and B(C6F5)3 under N2 – NMR: A solution of Cp*2Fe (0.0130 g, 0.040 mmol) and 
B(C6F5)3 (0.0202 g, 0.040 mmol) in CD2Cl2 (0.6 mL) was added to a J. Young NMR tube 
and monitored over time by 1H and 19F NMR spectroscopy (see Figure S3-4). 
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Cp*2Fe and B(C6F5)3 under N2 – UV-vis: A mixed solution of Cp*2Fe (0.0131 g, 0.040 
mmol) and B(C6F5)3 (0.0203 g, 0.040 mmol) in DCM (1 mL) was left standing in a 
sealed 1 dram vial in a nitrogen filled glovebox over 26 hours at room temperature. 
Aliquots of the reaction were diluted by a factor of 0.06 in DCM and the formation of 
Cp*2Fe+ monitored by UV-vis spectroscopy (see Figure S6). 
 
Cp*2Fe and B(C6F5)3 under vacuum: In the glovebox, a solution of Cp*2Fe (0.0133 g, 
0.041 mmol) in CD2Cl2 (0.3 mL) was added to a J. Young NMR tube and frozen in the 
cold well cooled by liquid N2. A solution of B(C6F5)3 (0.0211 g, 0.041 mmol) in CD2Cl2 
(0.3 mL) was layered on top of the frozen Cp*2Fe solution, and the tube frozen again in 
the cold well. The J. Young NMR tube was then sealed, removed from the glovebox and 
immediately submersed in an acetone/dry ice bath. The solution was degassed at -80 °C 
and then allowed to warm to room temperature. The reaction was monitored over time by 
1H and 19F NMR spectroscopy (see Figure S7-8). 
 
Cp*2Fe, B(C6F5)3, and O2: A solution of B(C6F5)3 (0.0259 g, 0.051 mmol) and Cp*2Fe  
(0.0188 g, 0.057 mmol) in CD2Cl2 (0.6 mL) was degassed via three freeze-pump-thaw 
cycles in a J. Young NMR tube. An atmosphere of O2 was admitted to the headspace of 
the tube. Upon inversion of the tube an immediate color change from yellow-orange to a 
dark green occurred. 1H and 19F NMR spectroscopy revealed a single new species (see 
Figures S9-10). After approximately 30 minutes a generous amount of dichroic green-
blue crystals was observed in the tube. 
 
Cp*2Fe, B(C6F5)3, and O2 in the dark: The above procedure was repeated using B(C6F5)3 
(0.0258 g, 0.051 mmol) and Cp*2Fe (0.0196 g, 0.057 mmol) in CD2Cl2 (0.6 mL) with the 
modification that the J. Young tube was wrapped in aluminum foil to prevent the 
admittance of any light into the reaction, and the lights were turned off to prevent 
exposure during transfer into the NMR probe. The same new species was observed by 1H 
and 19F NMR spectroscopy as above (see Figures S11-12). 
 
Cp2Fe, B(C6F5)3, and O2: A solution of B(C6F5)3 (0.0258 g, 0.050 mmol) and Cp2Fe  
(0.0109 g, 0.059 mmol) in CD2Cl2 (0.6 mL) was degassed via three freeze-pump-thaw 
cycles in a J. Young NMR tube. An atmosphere of O2 was admitted to the headspace and 
the reaction was inverted continuously and monitored by 1H and 19F NMR spectroscopy 
over time. After 7 hours at room temperature the solution had darkened to a deep blue 
and all of the B(C6F5)3 had been consumed and a single major new species was observed 
by 1H and 19F NMR spectroscopy (see Figures S13-14). After degassing the solution via 
three freeze-pump-thaw cycles the color had turned back to green-blue and significant 
decomposition was observed by 19F NMR spectroscopy (see Figures S15-16). Repeating 
the experiment without degassing can result in the formation of crystals suitable for X-
ray diffraction. 
 
NMR Scale Reactions in the Presence of Additives 
Cp*2Fe, B(C6F5)3, and O2 with 2,6-di-tert-butyl-4-methylpyridine (DTBMP): A solution 
of B(C6F5)3 (0.0213 g, 0.0416 mmol), Cp*2Fe (0.0142 g, 0.0435 mmol), and DTBMP 
(0.0084 g, 0.0409 mmol) in CD2Cl2 (0.6 mL) was degassed via three freeze-pump-thaw 
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cycles in a J. Young NMR tube. An atmosphere of O2 was admitted to the headspace of 
the tube. Upon inversion of the tube an immediate color change from yellow-orange to a 
dark green occurred. 1H and 19F NMR spectroscopy revealed the formation of [12-
][Cp*2Fe+]2 (see Figures S17-18). 
 
Cp2Fe, B(C6F5)3 and O2 with DTBMP in parallel with Cp2Fe, B(C6F5)3 and O2: A 
solution of B(C6F5)3 (0.0202 g, 0.0395 mmol), Cp2Fe (0.0074 g, 0.0398 mmol), and 
DTBMP (0.0082 g, 0.0399 mmol) in CD2Cl2 (0.6 mL) was degassed via three freeze-
pump-thaw cycles in a J. Young NMR tube. At the same time, a solution of B(C6F5)3 
(0.0214 g, 0.0418 mmol) and Cp2Fe (0.0082 g, 0.0441 mmol) was degassed via three 
freeze-pump-thaw cycles in a second J. Young NMR tube. An atmosphere of O2 was 
admitted to the headspace of each tube, and the reactions followed by 1H and 19F NMR 
spectroscopy (see Figures S19-20). After approximately 2 hours at room temperature, 
crystals of the product [12-][Cp2Fe+]2 began forming in both tubes, complicating 
qualitative comparison of the rate of the two reactions by NMR spectroscopy. Overall, 
the reaction appears unaffected by the presence of DTBMP. 
 
Cp2Fe, B(C6F5)3 and H(OEt2)2BArF24: A solution of B(C6F5)3 (0.0119 g, 0.0232 mmol), 
Cp2Fe (0.0051 g, 0.0274 mmol), and H(OEt2)2BArF24 (0.0017 g, 0.00168 mmol) in 
CD2Cl2 was degassed via three freeze-pump-thaw cycles. An atmosphere of O2 was 
admitted to the headspace and the reaction was inverted continuously, monitoring by 1H 
and 19F NMR spectroscopy over time. After approximately 3 hours the B(C6F5)3 had been 
converted to a mixture of [12-][Cp2Fe+]2 and other species (see Figures S21-22). 
 
Cp2Fe, B(C6F5)3 and H(OEt2)2BArF24: The reaction was repeated as above using 
B(C6F5)3 (0.0113 g, 0.0221 mmol), Cp2Fe (0.0046 g, 0.0256 mmol), and H(OEt2)2BArF24  
(0.0095 g, 0.00938 mmol) in CD2Cl2 (0.6 mL). After approximately 2 hours the B(C6F5)3 
had been converted to a mixture of species with negligible [12-][Cp2Fe+]2 observed (see 
Figures S23-24). Crystals formed from this reaction were identified by a preliminary 
crystal structure as [{(F5C6)B}2OH-][Cp2Fe+] in  (see Figure S36). 
 
Miscellaneous Reactions 
Reaction of [12-][Cp*2Fe+]2•2CH2Cl2 with H(OEt2)2BArF24: [12-][Cp*2Fe+]2•2CH2Cl2 
(0.0095 g, 0.00506 mmol) was added to a solution of H(OEt2)2BArF24 (0.0055g, 0.00543 
mmol) in CD2Cl2 (0.6 mL), and the reaction products observed by 1H and 19F NMR 
spectroscopy (see Figures S25-26). 
 
Reaction of [12-][Cp2Fe+]2 with H(OEt2)2BArF24: [12-][Cp2Fe+]2 (0.0030 g, 0.00160 
mmol) was added to a solution of H(OEt2)2BArF24 (0.0023g, 0.00227 mmol) in CD2Cl2 
(0.6 mL), and the reaction products observed by 1H and 19F NMR spectroscopy (see 
Figures S27-28). 
 
Reaction of B(C6F5)3 with DABCO•2H2O2 and DABCO: B(C6F5)3 (0.0221 g, 0.0432 
mmol) was added to a solution of DABCO•2H2O2 (0.0020 g, 0.0111 mmol) and DABCO 
(0.0016 g, 0.0143 mmol) in CD2Cl2 (0.6 mL) and the reaction products observed by 1H 
and 19F NMR spectroscopy (see Figures S29-30). 
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Synthesis of bis(decamethylferrocenium) 
bis(tris(pentafluorophenyl)boranyl)peroxide [12-][Cp*2Fe +]2•2CH2Cl2 
 
B(C6F5)3 (0.1336 g, 0.261 mmol) and Cp*2Fe (0.0861 g, 0.264 mmol) were combined in 
DCM (2 mL) and added to a Schlenk tube charged with a stir bar. The tube was then 
removed from the glovebox and taken to the Schlenk line where the solution was 
degassed via three freeze-pump-thaw cycles. Next, an atmosphere of O2 was added to the 
headspace with rapid stirring. After 5 seconds the solution had turned from yellow-
orange to deep forest green. After 2 minutes the stirring was stopped and the solution left 
standing at room temperature. After 10 minutes at room temperature dichroic crystals 
began forming. After 30 minutes at room temperature the solution was degassed via three 
freeze-pump-thaw cycles, and the Schlenk tube was taken back into the glovebox and the 
crystals collected on a medium porosity glass frit, washing with minimal amounts of cold 
DCM. The crystals were then dried under vacuum to yield 0.1297g (53.9%) of the titular 
compound. 1H NMR (300 MHz, CD2Cl2 , 25 °C): δ -34.7 ppm (br). 19F NMR (125 MHz, 
CD2Cl2 , 25 °C): δ -130.0 (br), -164.7 (br), -168.0 (br). λmax (DCM, nm), ε (M-1cm-1): 
780, 1091; 710, 653; 650, 444. Anal. Calcd for [12-][Cp*2Fe +]2•2CH2Cl2, 
C78H64B2Cl4F30Fe2O2: C, 49.87; H, 3.43. Found: C, 50.04; H, 3.49. 
 
Synthesis of bis(ferrocenium) bis(tris(pentafluorophenyl)boranyl)peroxide [12-
][Cp2Fe+]2 
 
B(C6F5)3 (0.0113g, ) and Cp2Fe (0.0043 g, ) were combined in DCM (0.4 mL) and added 
to a J. Young NMR tube. The tube was removed from the glovebox and taken to the 
Schlenk line. The solution was degassed via three freeze-pump-thaw cycles and an 
atmosphere of O2 was added to the headspace. The tube was then continuously inverted 
for several hours. Over the course of 30-60 minutes the solution changed from orange to 
green to dark blue. After 2 hours, some dark blue crystals began forming in the tube. 
After five hours, the reaction had gone to completion by 19F NMR spectroscopy. After 7 
hours, the solution was degassed via three freeze-pump-thaw cycles and taken back into 
the glovebox. The crystals were then collected on a medium porosity glass frit, washing 
with minimal amounts of cold DCM. The crystals were then dried under vacuum to yield 
0.0043 g (27%) of the desired compound. 1H NMR (300 MHz, CD2Cl2 , 25 °C): δ 31.9 
ppm (br). 19F NMR (125 MHz, CD2Cl2 , 25 °C): δ -139.8 (br), -165.8 (br), -172.4 (br). 
Anal. Calcd for [12-][Cp2Fe +]2•CH2Cl2, C57H22B2Cl2F30Fe2O2: C, 45.25; H, 1.47. Found: 
C, 45.13; H, 1.56. 
 
Synthesis of ferrocenium bis(tris(pentafluorophenyl)boranyl)hydroxide 
[[(F5C6)3B]2OH-][Cp2Fe+] 
 
B(C6F5)3 (0.0113 g, 0.0221 mmol), Cp2Fe (0.0046 g, 0.0256 mmol), and H(OEt2)2BArF24  
(0.0095 g, 0.00938 mmol) were combined in DCM (0.5 mL) and added to a J. Young 
NMR tube. The solution was degassed via three freeze-pump-thaw cycles and an 
atmosphere of O2 was added to the headspace. The tube was then continuously inverted 
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for several hours, monitoring by 19F NMR spectroscopy. After approximately 2 hours the 
B(C6F5)3 had been converted to a mixture of species with negligible [12-][Cp2Fe+]2 
observed. After approximately 3 hours dark blue crystals formed in the tube, and after 
degassing were isolated by filtration on a fine porosity glass frit, washing with minimal 
amounts of cold DCM. The crystals were then dried under vacuum to yield 0.0047 g 
(35%) of the titular compound. A single crystal X-ray diffraction study was performed on 
this material (Figure S36). 1H NMR (300 MHz, CD2Cl2 , 25 °C): δ 30.7 ppm (br). 19F 
NMR (125 MHz, CD2Cl2 , 25 °C): δ -135.2 (br), -159.1 (br), -164.7 (br).  
S8 
 
 
 
Figure S1. 19F NMR spectra of B(C6F5)3 under O2 (1 atm) at 5 min. (bottom) and 24 
hours (top) in CD2Cl2 at 25 °C. 
 
 
Figure S2. 1H NMR spectra of Cp*2Fe under O2 (1 atm) at 5 min. (bottom) and 24 hours 
(top) in CD2Cl2 at 25 °C. 
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Figure S3. 1H NMR spectra of Cp*2Fe and B(C6F5)3 under N2 at 15 min. (bottom) and 12 
hours (top) CD2Cl2 at 25 °C. 
 
Figure S4. 19F NMR spectra of Cp*2Fe and B(C6F5)3 under N2 at 15 min. (bottom) and 12 
hours (top) CD2Cl2 at 25 °C. 
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Figure S5. UV-vis spectrum of [12-][Cp*2Fe+]2 in DCM with varying concentration. 
 
 
Figure S6. UV-vis monitoring of the NMR concentration reaction of Cp*2Fe and 
B(C6F5)3 in DCM under N2. Aliquots of the reaction were taken over time and diluted by 
a factor of 0.06. The absorption at 780 nm was measured to determine the amount of 
Cp*2Fe+ generated. After 26 hours at room temperature, less than 15% of the total Cp*2Fe 
had been oxidized to Cp*2Fe+. 
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Figure S7. 1H NMR spectra of Cp*2Fe and B(C6F5)3 under vacuum at 15 min. (bottom) 
and 12 hours (top) CD2Cl2 at 25 °C. 
 
Figure S8. 19F NMR spectra of Cp*2Fe and B(C6F5)3 under vacuum at 15 min. (bottom) 
and 12 hours (top) CD2Cl2 at 25 °C. 
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Figure S9. 1H NMR spectrum of Cp*2Fe and B(C6F5)3 under O2 (1 atm) in CD2Cl2 at 25 
°C. 
 
Figure S10. 19F NMR spectrum of Cp*2Fe and B(C6F5)3 under O2 (1 atm) in CD2Cl2 at 25 
°C. 
 
Figure S11. 1H NMR spectrum of Cp*2Fe and B(C6F5)3 in the dark under O2 (1 atm) in 
CD2Cl2 at 25 °C. 
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Figure S12. 1H NMR spectrum of Cp*2Fe and B(C6F5)3 in the dark under O2 (1 atm) in 
CD2Cl2 at 25 °C. 
 
Figure S13. 1H NMR spectrum of Cp2Fe and B(C6F5)3 under O2 (1 atm) after 7 hours in 
CD2Cl2 at 25 °C. 
 
Figure S14. 19F NMR spectrum of Cp2Fe and B(C6F5)3 under O2 (1 atm) after 7 hours in 
CD2Cl2 at 25 °C. 
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Figure S15. 1H NMR spectrum of Cp2Fe and B(C6F5)3 under O2 (1 atm) after degassing 
in CD2Cl2 at 25 °C. 
 
Figure S16. 19F NMR spectrum of Cp2Fe and B(C6F5)3 under O2 (1 atm) after degassing 
in CD2Cl2 at 25 °C. 
 
Figure S17. 1H NMR spectrum of Cp*2Fe, B(C6F5)3, and DTBMP under O2 (1 atm) in 
CD2Cl2 at 25 °C. 
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Figure S18. 19F NMR spectrum of Cp*2Fe, B(C6F5)3 and DTBMP under O2 (1 atm) in 
CD2Cl2 at 25 °C. 
 
 
Figure S19. 1H NMR spectrum of Cp2Fe and B(C6F5)3 under O2 (1 atm) after 3 hours in 
CD2Cl2 at 25 °C  (bottom) and Cp2Fe, B(C6F5)3 and DTBMP under O2 (1 atm) after 3 
hours in CD2Cl2 at 25 °C (top). 
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Figure S20. 19F NMR spectrum of Cp2Fe and B(C6F5)3 under O2 (1 atm) after 3 hours in 
CD2Cl2 at 25 °C  (bottom) and Cp2Fe, B(C6F5)3 and DTBMP under O2 (1 atm) after 3 
hours in CD2Cl2 at 25 °C (top). 
 
Figure S21. 1H NMR spectrum of Cp2Fe, B(C6F5)3 and H(OEt2)2BArF24 under O2 (1 
atm) after 3 hours in CD2Cl2 at 25 °C. 
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Figure S22. 19F NMR spectrum of Cp2Fe, B(C6F5)3 and H(OEt2)2BArF24 under O2 (1 
atm) after 3 hours in CD2Cl2 at 25 °C. 
 
Figure S23. 1H NMR spectrum of Cp2Fe, B(C6F5)3 and H(OEt2)2BArF24 under O2 (1 
atm) after 2 hours in CD2Cl2 at 25 °C. 
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Figure S24. 19F NMR spectrum of Cp2Fe, B(C6F5)3 and H(OEt2)2BArF24 under O2 (1 
atm) after 3 hours in CD2Cl2 at 25 °C (bottom) and crystals of [{(F5C6)3B}2OH-][Cp2Fe+] 
isolated from the reaction mixture in CD2Cl2 at 25 °C (top). 
 
Figure S25. 1H NMR spectrum of [12-][Cp*2Fe+]2 and H(OEt2)2BArF24 in CD2Cl2 at 25 
°C. 
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Figure S26. 19F NMR spectrum of [12-][Cp*2Fe+]2 and H(OEt2)2BArF24 in CD2Cl2 at 25 
°C. 
 
Figure S27. 1H NMR spectrum of [12-][Cp2Fe+]2 and H(OEt2)2BArF24 in CD2Cl2 at 25 
°C. 
 
Figure S28. 19F NMR spectrum of [12-][Cp2Fe+]2 and H(OEt2)2BArF24 in CD2Cl2 at 25 
°C. 
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Figure S29. 1H NMR spectrum of B(C6F5)3, DABCO•2H2O2, and DABCO in CD2Cl2 at 
25 °C. 
 
Figure S30. 19F NMR spectrum of B(C6F5)3, DABCO•2H2O2, and DABCO in CD2Cl2 at 
25 °C. 
 
 
 
Figure S31. 1H NMR spectrum of [12-][Cp*2Fe+]2 in CD2Cl2 at 25 °C. 
S21 
 
Figure S32. 19F NMR spectrum of [12-][Cp*2Fe+]2 in CD2Cl2 at 25 °C. 
 
 
Figure S33. Variable scan rate cyclic voltammograms of [12-][Cp*2Fe+]2 in 0.1 M 
[nBu4N+][PF6-] in DCM with glassy carbon electrode. Potentials referenced to 
Cp2Fe/Cp2Fe+. 
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Crystallographic Information 
CCDC 1000579 and 1023005 contain the supplementary crystallographic data for this 
paper. These data can be obtained free of charge from The Cambridge Crystallographic 
Data Centre via www.ccdc.cam.ac.uk/data_request/cif.  
 
Refinement Details  
In each case, crystals were mounted on a glass fiber or nylon loop using Paratone oil, 
then placed on the diffractometer under a nitrogen stream. Low temperature (100 K) X-
ray data were obtained on a Bruker APEXII CCD based diffractometer (Mo sealed X-ray 
tube, Kα = 0.71073 Å) or a Bruker SMART CCD based diffractometer (Mo sealed X-ray 
tube, Kα = 0.71073 Å). All diffractometer manipulations, including data collection, 
integration, and scaling were carried out using the Bruker APEXII software.3 Absorption 
corrections were applied using SADABS.4 Space groups were determined on the basis of 
systematic absences and intensity statistics and the structures were solved by direct 
methods using XS5 or by intrinsic phasing using XT (incorporated into SHELXTL) and 
refined by full-matrix least squares on F2. All non-hydrogen atoms were refined using 
anisotropic displacement parameters. Hydrogen atoms were placed in the idealized 
positions and refined using a riding model. The structure was refined (weighed least 
squares refinement on F2) to convergence. Graphical representation of structures with 
50% probability thermal ellipsoids was generated using Diamond visualization software.6 
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Table 1. Crystal and refinement data for [12-][Cp*2Fe+]2•2CH2Cl2 and [12-][Cp2Fe+]2. 
Compound [12-][Cp*2Fe+]2•2CH2Cl2 [12-][Cp2Fe+]2 
CCDC 1000579 1023005 
empirical formula C38H32BCl2F15FeO C28H10BF15FeO 
formula wt 1878.41 g/mol 1428.04 
T (K) 100 100 
a, Å 11.330(2) 10.5469(9) 
b, Å 14.003(3) 10.646(1) 
c, Å 14.176(3) 12.043(1) 
α, deg 114.17(3) 77.024(3) 
β, deg 105.17(3) 88.081(4) 
γ, deg 96.41(3) 71.474(3) 
V, Å3 1918.3(7) 1248.3(2) 
Z 1 1 
cryst syst Triclinic Triclinic 
space group P-1 P-1 
dcalc, g/cm3 1.626 1.900 
θ range, deg 2.20 to 43.57 2.38 to 30.58 
µ , mm-1 0.639 0.742 
abs cor Multi-scan Multi-scan 
GOFa 0.961 0.9420 
R1b, wR2c (I > 2sig(I)) 0.0599, 0.1920 0.0869, 0.2449 
Diffractometer SMART APEXII 
a GOF = S = { Σ [w(Fo2-Fc2)2] / (n-p) }1/2 
b R1 = Σ||Fo|-|Fc|| / Σ|Fo| c wR2 = { Σ [w(Fo2-Fc2)2] / Σ [w(Fo2)2] }1/2  
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Figure S34. Structural drawing of [12-][Cp*2Fe+]2•2CH2Cl2 with 50% probability 
ellipsoids. Hydrogen atoms and solvent molecules not shown for clarity. Carbon and 
fluorine atoms shown in black and green, respectively. 
 
Figure 35. Structural drawing of [12-][Cp2Fe+] with 50% probability ellipsoids. Hydrogen 
atoms not shown for clarity. Carbon and fluorine atoms shown in black and green, 
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respectively. 
 
 
Figure 36. Preliminary crystal structure of [{(F5C6)3B}2OH-][Cp2Fe+]•2CH2Cl2. 
Hydrogen atoms and solvent molecules not shown for clarity. Carbon and fluorine atoms 
shown in black and green, respectively. 
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